|
The impact of self-reported social determinants of health (SDOH) on patient engagement and symptom burden across a remote patient monitoring (RPM) pathway in 42 European hospitals. |
|
|
Speakers' Bureau - Novartis (Inst) |
Research Funding - Resilience Care (Inst); Resilience Care (Inst) |
|
|
Honoraria - AstraZeneca; Novartis |
Consulting or Advisory Role - Sandoz |
Speakers' Bureau - Amgen; Kyowa Kirin International; MSD Oncology; Mundipharma; Roche; Sandoz |
Research Funding - Astellas Pharma (Inst); Bayer; Fresenius Kabi; Janssen Oncology (Inst); Pierre Fabre (Inst); Roche (Inst); Sandoz (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Novartis; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Honoraria - Baxter; Ethypharm; Merz GmbH; Mundipharma |
Consulting or Advisory Role - Accord Healthcare; Alfasigma; Kyowa Kirin International |
Travel, Accommodations, Expenses - Ethypharm; Ethypharm; Kyowa Kirin International |
|
|
Research Funding - GlaxoSmithKline (Inst); iTEOS Therapeutics (Inst); Lilly (Inst); PharmaMar (Inst); SERVIER (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Resilience Care |
Honoraria - Gilead Sciences; Merck Sharp & Dohme; Novartis; Roche; Seagen |
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Lilly |
|
|
Employment - Resilience Care |
|
|
Stock and Other Ownership Interests - Vector Science |
Consulting or Advisory Role - AstraZeneca; N-Power Medicine; Navigating Cancer; Resilience Care; Savor Health LLC; SIVAN Innovation; Verily |
Other Relationship - American Society of Clinical Oncology; Centers for Medicare and Medicaid Services; JAMA-Journal of the American Medical Association; National Cancer Institute; Patient-Centered OUtcomes Research Institute (PCORI) |
|
|
Honoraria - Amgen; BMS GmbH & Co. KG; Daichy Sankyo; Gilead Sciences; GlaxoSmithKline; Leo Phar; Pfizer; Pharmanovia; Thermofisher Scientific Biomarkers; Viatris |
Research Funding - Gilead Sciences |
Travel, Accommodations, Expenses - Pfizer |
|
|
No Relationships to Disclose |